Summarized by Plex Health
Last Updated: 03 May 2022

Dactinomycin is used to treat different types of cancers that affect the kidneys, uterus, testicles, bones, muscles, joints, and soft cells. Dactinomycin is used to treat solid tumors. Making use of dactinomycin might increase your risk of developing other cancers, such as leukemia. If the mommy or the dad is utilizing dactinomycin, dactinomycin can harm unborn baby or cause birth flaws. You might receive this medication regularly or less commonly, depending on the type of cancer you have. Dactinomycin can lower your blood cell matters. Your cancer therapies might be delayed based on the results. Dactinomycin can posture a health hazard to caregivers. Dactinomycin can cause nausea or vomiting and vomiting. The physician might suggest medication to keep you from feeling sick and regurgitating after you get dactinomycin. If you have pain or redness at the IV website, tell the registered nurse right away. This medicine may make your mouth aggravated and aching. The medical professional or nurse might give you oral rinses to keep your mouth tidy after you obtain dactinomycin. Definition from the NCI Drug Dictionary, Detailed scientific interpretation and other names for this medication. If they can assist deal with or protect against conditions other than the ones they are authorized for, drugs are usually examined to discover out. This patient information sheet applies only to accepted uses the medication. Nevertheless, much of the info may additionally relate to unapproved uses that are being studied. Discover Clinical Trials for Dactinomycin, Check for trials from NCI's list of cancer medical trials now accepting patients.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

PubChem - CovalentUnitCount

(Table source)
457193C62H86N12O161255.4CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)CC[[email protected]@H]1[[email protected]@H](C(=O)N[[email protected]@H](C(=O)N2CCC[[email protected]]2C(=O)N(CC(=O)N([[email protected]](C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)N[[email protected]]6[[email protected]](OC(=O)[[email protected]@H](N(C(=O)CN(C(=O)[[email protected]@H]7CCCN7C(=O)[[email protected]](NC6=O)C(C)C)C)C)C(C)C)C)N)CInChI=1S/C62H86N12O16/c1-27(2)42-59(84)73-23-17-19-36(73)57(82)69(13)25-38(75)71(15)48(29(5)6)61(86)88-33(11)44(55(80)65-42)67-53(78)35-22-21-31(9)51-46(35)64-47-40(41(63)50(77)32(10)52(47)90-51)54(79)68-45-34(12)89-62(87)49(30(7)8)72(16)39(76)26-70(14)58(83)37-20-18-24-74(37)60(85)43(28(3)4)66-56(45)81/h21-22,27-30,33-34,36-37,42-45,48-49H,17-20,23-26,63H2,1-16H3,(H,65,80)(H,66,81)(H,67,78)(H,68,79)/t33-,34-,36+,37+,42-,43-,44+,45+,48+,49+/m1/s1RJURFGZVJUQBHK-IIXSONLDSA-N2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide3.81254.628474701254.62847470356303005188900101000001
*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.


Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.